09.07.10
Oxis International, Inc., Beverly Hills, CA, and The Esteee Lauder Companies Inc. have resolved a dispute between Lauder's subsidiary, Applied Genetics Incorporated Dermatics ("AGI"), and Oxis over technology related to U.S. Patent Nos. 6,103,746 (the "746 Patent") and 6,479,533 (the "533 Patent") entitled "Methods and Compositions for the Protection of Mitochondria."
An agreement provides Oxis with full title to the '746 and '533 Patents in exchange for Estée Lauder receiving a non-exclusive license under the '746 and '533 Patents within the cosmetic market.
The material terms and conditions were not disclosed.